NOS3 and diabetic kidney disease: Finally, the levels of asymmetric dimethylarginin, an endogenous inhibitor of endothelial eNOS, contribute to increased risk of progressive DKD in patients with T1DM (71–73) and eNOS polymorphisms that result in reduced enzyme function have been associated with more advanced diabetic nephropathy (74, 75).